Healthy Skepticism Library item: 4471

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: news

Re: the promotion of pipenzolate/phenobarbital
1992 Mar

Abstract:

In Pakistan Ferozsons is marketing Piptal (a combination of pipenzolate and phenobarbital) under a licence from the subsidiary of Marion Merrell Dow. The product is being sold for the treatment of infantile colic. The scientific literature does not support the use of this product for this condition.

Keywords:
*analysis/Pakistan/developing countries/Piptal/children/colic/Ferozsons/Marion Merrell Dow/quality of information/safety & risk information/MaLAM/Medical Lobby for Appropriate Marketing/ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS/EVALUATION OF PROMOTION: DRUG SAFETY/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES